A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of MEDI5884 in Adults With Stable Coronary Heart Disease

Completed · Phase 2 · Has a placebo group

Conditions studied: Stable Coronary Heart Disease

In brief

A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of MEDI5884 in Adults With Stable Coronary Heart Disease.

Key facts

Study ID
NCT03351738
Run by
MedImmune LLC
People needed
133
Starts
2017-12-13
Expected to finish
2018-11-09
Last updated by the study team
2020-03-23

Who can join

Age: 45 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.